K.M. Venkat Narayan, MD; Mary Beth Weber, PhD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0798.
Requests for Single Reprints: K.M. Venkat Narayan, MD, Rollins School of Public Health, 1518 Clifton Road Northeast, Atlanta, GA, 30322; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Venkat Narayan and Weber: Rollins School of Public Health, 1518 Clifton Road Northeast, Atlanta, GA, 30322.
Narayan KV, Weber MB. Screening for Hyperglycemia: The Gateway to Diabetes Prevention and Management for All Americans. Ann Intern Med. 2015;162:795-796. doi: 10.7326/M15-0798
Download citation file:
Published: Ann Intern Med. 2015;162(11):795-796.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Bangladesh Institute of Family Medicine and Research
May 1, 2015
Do screen for hyperglycemia in all adults, reduce vascular complication burden
This is a good review. Not only in the US, earliest detection of IFG, IGT or asymptomatic overt T2DM is vital universally. We can go for either lifestyle modification alone or added pharmacological intervention in individuals with prediabetes (either IFG or IGT or both) not only to prevent progression to overt T2DM but to prevent vascular complications as well. In screen-detected asymptomatic T2DM patients, both lifestyle intervention and added drug therapy, if required, may reduce both micro and macrovascular complications. Routine screening for hyperglycemia in asymptomatic individuals will not cause too much financial burden but earliest detection may reduce treatment cost due to advanced vascular complications.
Cardiology, Endocrine and Metabolism, Diabetes, Coronary Risk Factors, Prevention/Screening.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only